| # | Drug | Count |
|---|---|---|
| 0 | ALEMTUZUMAB | 18 |
| 1 | ACETAMINOPHEN | 8 |
| 2 | METHYLPREDNISOLONE | 8 |
| 3 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 7 |
| 4 | DIPHENHYDRAMINE HYDROCHLORIDE | 7 |
| 5 | DIMENHYDRINATE | 6 |
| 6 | RANITIDINE | 5 |
| 7 | TEPROTUMUMAB | 5 |
| 8 | CIMETIDINE | 4 |
| 9 | ACYCLOVIR | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN ALBUMIN MICROSPHERES AND PERFLUTREN | 1 | 0.0071 |
| 1 | ESTRADIOL AND NORETHINDRONE ACETATE | 1 | 0.0026 |
| 2 | BARIUM SULFATE | 1 | 0.0023 |
| 3 | PROPARACAINE HYDROCHLORIDE | 1 | 0.0019 |
| 4 | ALEMTUZUMAB | 18 | 0.0009 |
| 5 | TEPROTUMUMAB | 5 | 0.0008 |
| 6 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 7 | POTASSIUM IODIDE | 1 | 0.0007 |
| 8 | DIMENHYDRINATE | 6 | 0.0006 |
| 9 | CIMETIDINE | 4 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 18 | 0.0009 |
| 2 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 5 | 0.0008 |
| 3 | Thyroid Hormone Synthesis Inhibitor [EPC] | 3 | 0.0003 |
| 4 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Contrast Agent for Ultrasound Imaging [EPC] | 1 | 0.0002 |
| 6 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 8 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 9 | Progesterone [EPC] | 1 | 0.0000 |